The mitochondrial carnitine/acylcarnitine carrier: function, structure and physiopathology
Average weight loss reached 12.7% (29.8 lbs) with the 4 mg dose, 19.1% (45.4 lbs) with the 9 mg dose, and 20.8% (49.6 lbs) with the 12 mg dose, compared with 4.0% (9.3 lbs) among participants receiving placebo
Important cautions: History of medullary thyroid carcinoma (MTC) or MEN2 , pancreatitis , gallbladder disease, severe GI disorders, certain drug interactions, and pregnancy/breastfeeding considerations
Mazdutide is supported by robust clinical data published in multiple high-impact journals, including Nature , the Lancet sub-journals, and the New England Journal of Medicine